JIC
Johnson Investment Counsel Portfolio holdings
AUM
$11.1B
1-Year Return
15.75%
This Quarter Return
+0.96%
1 Year Return
+15.75%
3 Year Return
+60.71%
5 Year Return
+113.42%
10 Year Return
+242.02%
AUM
$10.3B
AUM Growth
+$94.1M
(+0.93%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
33.09%
Holding
858
New
50
Increased
329
Reduced
274
Closed
69
Top Buys
| 1 |
IDEX
IEX
|
+$34.2M |
| 2 |
AbbVie
ABBV
|
+$27.8M |
| 3 |
PepsiCo
PEP
|
+$14.1M |
| 4 |
Microsoft
MSFT
|
+$14M |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$12.6M |
Top Sells
| 1 |
Hershey
HSY
|
+$32.9M |
| 2 |
Zimmer Biomet
ZBH
|
+$28.8M |
| 3 |
Estee Lauder
EL
|
+$25.6M |
| 4 |
S&P Global
SPGI
|
+$13.5M |
| 5 |
Apple
AAPL
|
+$6.76M |
Sector Composition
| 1 | Technology | 16.72% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 8.49% |
| 4 | Industrials | 8.37% |
| 5 | Consumer Staples | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
PLDT
PHI
$4.21B
| $455K | ﹤0.01% |
20,525
-3,375
| -14% | -$74.8K |
|
552
Corpay
CPAY
$22.1B
| $447K | ﹤0.01% |
1,321
| – | – |
|
553
AZZ Inc
AZZ
$3.41B
| $444K | ﹤0.01% |
+5,423
| New | +$444K |
|
554
United Therapeutics
UTHR
$18.3B
| $439K | ﹤0.01% |
1,245
| – | – |
|
555
Vale
VALE
$44.2B
| $432K | ﹤0.01% |
48,711
-7,090
| -13% | -$62.9K |
|
556
Electronic Arts
EA
$41.5B
| $431K | ﹤0.01% |
2,947
+912
| +45% | +$133K |
|
557
Vanguard Extended Market ETF
VXF
$24.1B
| $430K | ﹤0.01% |
2,266
| – | – |
|
558
Acuity Brands
AYI
$10.1B
| $428K | ﹤0.01% |
1,465
| – | – |
|
559
Arthur J. Gallagher & Co
AJG
$76.5B
| $427K | ﹤0.01% |
1,506
+401
| +36% | +$114K |
|
560
Rockwell Automation
ROK
$38.6B
| $425K | ﹤0.01% |
1,487
+77
| +5% | +$22K |
|
561
Fidelity Blue Chip Growth ETF
FBCG
$4.75B
| $419K | ﹤0.01% |
+9,058
| New | +$419K |
|
|
PSTX
562
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $419K | ﹤0.01% |
43,600
| – | – |
|
563
Horizon Bancorp
HBNC
$842M
| $417K | ﹤0.01% |
25,867
| – | – |
|
564
Churchill Downs
CHDN
$6.85B
| $415K | ﹤0.01% |
3,108
+338
| +12% | +$45.1K |
|
565
CGI
GIB
$21.3B
| $413K | ﹤0.01% |
3,774
-600
| -14% | -$65.6K |
|
566
Sarepta Therapeutics
SRPT
$1.85B
| $412K | ﹤0.01% |
3,388
+240
| +8% | +$29.2K |
|
567
KeyCorp
KEY
$20.9B
| $408K | ﹤0.01% |
23,787
+3,357
| +16% | +$57.5K |
|
568
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.43B
| $404K | ﹤0.01% |
5,717
+732
| +15% | +$51.8K |
|
569
Waters Corp
WAT
$17.9B
| $402K | ﹤0.01% |
1,084
-3
| -0.3% | -$1.11K |
|
570
Kayne Anderson Energy Infrastructure Fund
KYN
$2.07B
| $402K | ﹤0.01% |
31,634
| – | – |
|
571
SPDR S&P Homebuilders ETF
XHB
$1.92B
| $401K | ﹤0.01% |
3,842
| – | – |
|
572
Invesco S&P MidCap Quality ETF
XMHQ
$5.09B
| $401K | ﹤0.01% |
4,075
+1,000
| +33% | +$98.5K |
|
573
Sempra
SRE
$52.4B
| $401K | ﹤0.01% |
4,572
+1,051
| +30% | +$92.2K |
|
574
NVR
NVR
$22.9B
| $401K | ﹤0.01% |
49
| – | – |
|
575
Kinder Morgan
KMI
$59.2B
| $400K | ﹤0.01% |
14,591
+1,458
| +11% | +$40K |
|